ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF19.180

F19.180

Billable

Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F19.180 is a billable code used to indicate a diagnosis of other psychoactive substance abuse with psychoactive substance-induced anxiety disorder.

Key Diagnostic Point:

F19.180 refers to a condition characterized by the abuse of psychoactive substances that are not classified under other specific categories, leading to the development of anxiety disorders induced by the substance. Patients may experience heightened anxiety, panic attacks, and other anxiety-related symptoms as a direct result of substance use. This code encompasses a range of substances, including but not limited to hallucinogens, inhalants, and other non-specific psychoactive agents. The diagnosis requires a thorough assessment of the patient's substance use history, the timing of anxiety symptoms in relation to substance use, and the exclusion of other potential causes of anxiety. Treatment often involves a combination of substance use disorder interventions, such as counseling and rehabilitation programs, alongside management of anxiety symptoms, which may include pharmacotherapy and psychotherapy. Accurate coding is essential for appropriate treatment planning and reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of psychoactive substances that can lead to similar symptoms
  • Need for comprehensive patient history to establish causality
  • Differentiation from other anxiety disorders not induced by substances
  • Potential for co-occurring mental health disorders

Audit Risk Factors

  • Inadequate documentation of substance use history
  • Failure to specify the psychoactive substance involved
  • Lack of evidence for the temporal relationship between substance use and anxiety symptoms
  • Misclassification of anxiety symptoms as primary rather than substance-induced

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use and mental health history, treatment plans, and progress notes.

Common Clinical Scenarios

Patients presenting with anxiety symptoms following substance use, requiring assessment for substance-induced disorders.

Billing Considerations

Consideration of withdrawal symptoms and their impact on anxiety management.

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use patterns, treatment history, and psychosocial factors.

Common Clinical Scenarios

Patients in recovery experiencing anxiety as a result of previous substance abuse.

Billing Considerations

Integration of substance use treatment with mental health support.

Coding Guidelines

Inclusion Criteria

Use F19.180 When
  • Follow the ICD
  • CM coding guidelines for substance use disorders, ensuring accurate documentation of the relationship between substance use and anxiety symptoms
  • Include any relevant co
  • occurring conditions

Exclusion Criteria

Do NOT use F19.180 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

H0001CPT Code

Assessment of substance use disorder

Clinical Scenario

Used during initial evaluation of a patient with suspected substance-induced anxiety.

Documentation Requirements

Complete assessment of substance use history and mental health status.

Specialty Considerations

Psychiatric evaluation may require additional documentation of mental health history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance use disorders and their complications, improving the accuracy of diagnoses and treatment plans.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance use disorders and their complications, improving the accuracy of diagnoses and treatment plans.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance use disorders and their complications, improving the accuracy of diagnoses and treatment plans.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F19.180 and other anxiety disorder codes?

F19.180 specifically indicates that the anxiety disorder is induced by the use of psychoactive substances, whereas other anxiety disorder codes may represent primary anxiety disorders not related to substance use.